Health

After latest study, Bruce Yankner’s inbox exploded: ‘I try to get back to everybody … I try to provide hope.’

New system to address disorder that affects 8.2 million Americans shows promise in study

Where do science and ancient wisdom align? Take our quiz to find out.

Harvard chemists, inspired by group-testing strategy, develop faster way to identify useful catalyst combinations

Study finds orthopedists, who treat kind of injuries that result from partner violence, refer patients to programs at very low rates

Study looks at why risky behavior surged in wake of 2011 tsunami, earthquake

Experts discuss role of AI and other technology in future of mental health care

Some families, activists say term is too broad, masks unique issues of most severe cases as surging rates, federal plans turn spotlight on disorder

Immunologist says it’s not too late to get vaccinated

Medical ethicist details need to balance thoughtful limits while avoiding unnecessary hurdles as industry groups issue guidelines

If you’re not failing all the time, you’re doing it wrong, says fitness expert

Insurance data can help fill gaps between longer trials, researchers say

Research suggests even brief episodes of heavy alcohol consumption can injure small intestine

Experts see rise in gambling problems, possible wider cultural fallout

Why it’s worth trying, what to expect, and how to succeed

Constantly distracted by devices? Experts share strategies on reclaiming focus.

Take our quiz to score your lifestyle’s potential for preventing diseases like dementia

Study suggests stress reduction holds potential for cardiovascular disease prevention

40 percent of GLP-1 prescriptions go unfilled, study finds

In podcast, experts discuss different types of toxic achievers and the case for embracing your ‘beautiful mess’

‘Wildly different reactions’ among participants, says researcher

Could advance treatment of mental illness with greater precision, less medication

Research highlighting chronic inflammation opens path to treating illness that affects millions of Americans

Study finds most districts already regulate devices. Is the real issue enforcement?

New research shows negative voices are relatively rare in drug approval hearings.

AI, statistics offer new possibilities for personalized medicine

Campus debate weighs therapeutic need vs. safety questions

Findings suggest colibactin may be promising target for disease prevention

Michael VanRooyen started running toward trouble more than 30 years ago. He’s still going.

Closer look at two-part reaction may offer researchers insights into autoimmune disease